Latest Industry News & Trends
Market Scope provides comprehensive coverage of the ophthalmic market. Our news stories are a combination of public and proprietary content ranging from coverage of international meetings, surgeon survey results and trends, analysis of company financial reports and public medical registries, press releases, and interviews with executives. Register today to receive free weekly email updates, our top data chart, surgeon poll results, and much more. Locked content can be accessed through a subscription to our ophthalmic industry newsletters.
Recently Added News
FDA Panel Meeting for Sydnexis’ Rejected Myopia Drop Candidate Set for Oct. 30
Sydnexis reported Sept. 24 that the US FDA had set Oct. 30 as the date for an advisory committee and open public hearing to review the new drug application (NDA) for SYD-101, an atropine eye drop c...
Rayner Launches RayOne Galaxy IOL in US after Receiving FDA Approval
UK-based Rayner announced Sept. 24 that its RayOne Galaxy and RayOne Galaxy Toric IOLs were commercially available in the US after the lenses gained FDA approval. The company noted that US surgeons...
Roche Gains EU Approval for Susvimo Sustained-Release Wet AMD Treatment
Swiss drugmaker Roche announced Sept. 21 that the European Commission had granted marketing authorization for Susvimo (ranibizumab injection) 100 mg/mL for the treatment of wet age-related macular ...
Future of Ophthalmic Diagnostic Innovation May Hinge on Integration, Reliability
Manufacturers have invested heavily in AI, cloud connectivity, and digital applications over the past several years. These developments are continuing, but AI and digitalization are becoming less d...
Zeiss Introduces Alta Duo 300, a Fully Automated OCT Combination Retinal Imager
Zeiss Medical Technology reported Sept. 17 that it had introduced the Alta Duo 300 combination retinal imager. The device will be available in select markets later in 2026. The German company said ...
Combination OCT-Fundus Camera Headlines Product Launches from Nidek
Japan’s Nidek announced Sept. 3 the launch of three new ophthalmic diagnostic offerings. The RSD-1 Duo, a combined OCT and fundus camera system, and the AFC-1 fundus camera increase efficiency acro...
UK Pet Food Company Concludes Recall After Reports of Sudden Dry Eye Symptoms in Dogs
The Years pet food company, based in the UK, has concluded a recall of all its fresh pet food products after an independent investigation found no link between its ingredients and dog owners’ repor...
Bausch + Lomb Receives FDA Warning Letter for Tampa, Florida, Plant, Citing Persistent Contamination
The US FDA sent Bausch + Lomb a warning letter Sept. 4 regarding significant violations observed at its manufacturing plant in Tampa, Florida, during an FDA inspection in March 2026. The Tampa loca...
€1 Million Champalimaud Vision Award in 2026 Goes to Botond Roska and José-Alain Sahel
The winners of the 2026 António Champalimaud Vision Award are researchers Botond Roska, MD, PhD, of Switzerland, and José-Alain Sahel, MD, of France and the US, for their pioneering optogenetic the...
Norlase Establishes Direct Commercial Presence in the United Kingdom
Norlase announced on Sept. 8 that it had expanded its footprint in Europe with a direct commercial presence in the United Kingdom. The Danish company, with US offices in Redwood City, California, a...
Chinese Regulators Accept NDA for Low-Dose Atropine Drop for Myopia from Santen
Japan’s Santen announced Sept. 14 that China’s National Medical Products Administration (NMPA) had accepted the new drug application (NDA) for STN1012700 (atropine sulfate ophthalmic solution 0.025...
Ophthalmologists Report 5.4 Percent Decrease in Q2-2026 Procedure Volume
US ophthalmologists reported that ophthalmic procedures decreased 5.4 percent in Q2-2026 compared with the same quarter in 2025, according to Market Scope’s latest survey. Year-over-year performanc...
Past News Stories
Ophthalmic Company Revenue Drops 0.8 Percent in Second Quarter of 2026
Ophthalmic manufacturer revenue in Q2-2026 totaled $11.8 billion. Revenue decreased 0.8 percent from the same quarter in 2025 and increased 3.3 percent from Q1-2026. The total includes Market Scope...
New IRD Therapies Could Shake Up Nonexudative Retinal Pharma Market
Complement inhibitors reaped more than three-quarters of manufacturers’ revenue in the nonexudative retinal pharmaceuticals market in 2025, but candidates for inherited retinal diseases (IRD) are g...
Ophthalmologist Urges Early Intervention in Dry Eye Management to Avoid Surprises
Jason Bacharach, MD, of North Bay Eye Associates in northern California, has a word of advice for ophthalmologists and optometrists. Four words, actually: interventional dry eye management (IDEM). ...
Alcon Launches Unity M Ophthalmic Surgical Microscope
Alcon announced Sept. 3 the initial commercial launch of its Unity M ophthalmic surgical microscope. The company said the microscope, which has received CE marking in Europe and regulatory approval...
Select US FDA Approvals and Clearances in August 2026
The US FDA’s ophthalmic device division granted clearance to three devices using the 510(k) pathway in August 2026, according to the agency’s database. Sight Sciences received clearance for a label...
PDUFA Dates for Ophthalmic Drug Candidates, September 2026
The US FDA has scheduled the following Prescription Drug User Fee Act (PDUFA) and Biosimilar User Fee Act (BsUFA) target action dates for ophthalmic drug, drug/device, and biologic candidates.
Bausch + Lomb Gains CE Marking for SeeLyra Femtosecond Laser
Bausch + Lomb reported Sept. 11 that its SeeLyra next-generation femtosecond laser had gained CE marking. The company said the SeeLyra, built on the Victus platform, is designed to provides surgeon...
EyePoint’s Duravyu Misses Primary Visual Acuity Endpoint in Phase III Wet AMD Trial
EyePoint Pharmaceuticals reported Aug. 17 that Duravyu (vorolanib intravitreal insert) missed its primary visual acuity endpoint in topline results from the Phase III LUGANO trial in wet age-relate...
Balance Announces 2026 Medicare Pricing for FSYX Pump and Goggles
Balance Ophthalmics reported Aug. 18 that regulators had set 2026 Medicare payment amounts for the FSYX Ocular Pressure Adjusting Pump (OPAP) and associated goggles, effective Oct. 1. The FSYX pump...
UK Government Outlines Measures to Reduce Ophthalmology Waiting Times
The UK government on Aug. 25 outlined initiatives intended to reduce ophthalmology waiting times, address regional disparities, and move more eye care into community and digital settings. Gillian J...
Oxford Eye Hospital Initiative Cuts IVT Injection Waste and Costs
Britain’s Oxford Eye Hospital reported Aug. 24 that an initiative there to change the way intravitreal (IVT) injections are administered has eliminated tons of associated single-use product waste a...
Ingenia Leads Latest Fundraising with $42.3 Million Initial Public Offering
Ingenia Therapeutics led recent ophthalmic fundraising efforts, which totaled $57.3 million in the past four weeks.
Want to Read the Full Article?
Already Have an Account?
Register A Corporate Account
A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.